State of Wyoming Acquires 13,852 Shares of Amrize Ltd $AMRZ

State of Wyoming lifted its stake in shares of Amrize Ltd (NYSE:AMRZ) by 115.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 25,898 shares of the company’s stock after purchasing an additional 13,852 shares during the quarter. State of Wyoming’s holdings in Amrize were worth $1,451,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Geode Capital Management LLC bought a new position in Amrize in the 2nd quarter valued at $265,000. M&T Bank Corp bought a new position in shares of Amrize in the second quarter worth $205,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Amrize in the second quarter worth $3,870,000. Gabelli Funds LLC purchased a new stake in shares of Amrize in the second quarter worth $1,083,000. Finally, AXA S.A. purchased a new stake in shares of Amrize in the second quarter worth $1,065,000.

Insiders Place Their Bets

In other news, insider Mario Gross bought 2,800 shares of the stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $49.17 per share, with a total value of $137,676.00. Following the completion of the acquisition, the insider owned 33,747 shares in the company, valued at $1,659,339.99. The trade was a 9.05% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jan Philipp Jenisch purchased 21,417 shares of Amrize stock in a transaction dated Friday, May 15th. The shares were acquired at an average cost of $49.67 per share, with a total value of $1,063,782.39. Following the transaction, the chief executive officer directly owned 1,724,999 shares in the company, valued at approximately $85,680,700.33. The trade was a 1.26% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders acquired 54,920 shares of company stock valued at $2,717,429. Insiders own 0.54% of the company’s stock.

Amrize Trading Up 2.0%

NYSE:AMRZ opened at $49.66 on Thursday. The company has a 50-day moving average price of $52.14 and a 200-day moving average price of $55.20. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $65.94. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. The stock has a market cap of $27.46 billion and a price-to-earnings ratio of 23.76.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion for the quarter. The business’s revenue was up 4.7% on a year-over-year basis. Equities analysts predict that Amrize Ltd will post 2.74 EPS for the current year.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is presently 21.05%.

Wall Street Analyst Weigh In

AMRZ has been the subject of several recent analyst reports. Wells Fargo & Company reduced their target price on Amrize from $65.00 to $58.00 and set an “overweight” rating for the company in a research report on Wednesday, July 8th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Truist Financial reaffirmed a “hold” rating and set a $48.00 price objective (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. Oppenheimer dropped their price target on Amrize from $68.00 to $65.00 and set an “outperform” rating for the company in a research note on Tuesday. Finally, Weiss Ratings lowered shares of Amrize from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $62.79.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.